Last reviewed · How we verify

"Basel phenotyping cocktail" capsule — Competitive Intelligence Brief

"Basel phenotyping cocktail" capsule ("Basel phenotyping cocktail" capsule) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Pharmacogenomics / Clinical Pharmacology.

marketed Pharmacogenomics / Clinical Pharmacology Small molecule Live · refreshed every 30 min

Target snapshot

"Basel phenotyping cocktail" capsule ("Basel phenotyping cocktail" capsule) — University Hospital, Basel, Switzerland. A diagnostic cocktail containing probe drugs that assess the activity of multiple cytochrome P450 enzymes and other drug-metabolizing pathways in vivo.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
"Basel phenotyping cocktail" capsule TARGET "Basel phenotyping cocktail" capsule University Hospital, Basel, Switzerland marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). "Basel phenotyping cocktail" capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/basel-phenotyping-cocktail-capsule. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: